Medical Disclaimer: This site provides informational comparisons only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before making medication decisions.
Compare ADALIMUMAB-ADBM (Cyltezo) and ADALIMUMAB-RYVK (Simlandi) — clinical data, side effects, and patient experiences.
Cyltezo · TNF Inhibitor
How it works
12.1 Mechanism of Action Adalimumab products bind specifically to TNF-alpha and block its interaction with the p55 and p75 cell surface TNF receptors. Adalimumab products also lyse...
Approved for
Simlandi · TNF Inhibitor
How it works
12.1 Mechanism of Action Adalimumab products bind specifically to TNF-alpha and block its interaction with the p55 and p75 cell surface TNF receptors. Adalimumab products also lyse...
Approved for
Estimated frequency (%) based on clinical trial data
Based on 14 Reddit discussions
ADALIMUMAB-ADBM
43%
positive
7 threads
ADALIMUMAB-RYVK
29%
positive
7 threads
% of discussions mentioning each side effect
7 Reddit threads analysed for ADALIMUMAB-ADBM
Overall Sentiment
Mixed
Comparison Threads
0
Avg Post Score
13 upvotes
Most discussed side effects in community
I just needed to tell someone, I did my injection (Adalimumab-adbm) by myself for the first time yesterday. My husband usually does it, but unfortunately we are having issues and I just decided I need to do this myself rather than rely on him. I am proud of myself. However, I am not sure if I did s
And I have already looked into it, read research papers, first hand accounts on here and talked to both my doctors and my specialty pharmacist. Who all 3 agree that if they had it their way I would stay on Humira and tried to fight for it. All that said I'm hoping it's no different or better! I've
UPDATES BELOW: I feel like i"m about to lose my mind. I've been in so much pain for a year now. So fatigued. What are your experiences with such a denial, appeal, and plan of care ? May 2023: first R visit By the time we did all the tests I was able to get on Otezla in October 2023. Had to
Hey, everyone 👋🏼 I (27M) was diagnosed with AS last August after a relatively short process of looking into my years-chronic upper back pain. My rheumatologist had a lot of previous experience with AS, and my symptoms checked all the boxes for her after we did some testing. Through the Fall, I sta
I finally got somewhere with my rheumatologist, and I'll be starting Adalimumab-adbm. I have BCBS insurance, and my pharmacy benefits manager is Express Scripts. I've had nightmare experiences with Express Scripts and my asthma medication that requires prior authorization renewals, so I'm not unfam
Have taken 2doses of Adalimumab-adbm so far and now the skin around my spots and plaques is peeling. Looks like a sunburn peel…anyone else experience this? Never happened with any of the biologics ive been on so far, even when they cleared it never peeled like this…
Have taken 2doses of Adalimumab-adbm so far and now the skin around my spots and plaques is peeling. Looks like a sunburn peel…anyone else experience this? Never happened with any of the biologics ive been on so far, even when they cleared it never peeled like this…
Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.
7 Reddit threads analysed for ADALIMUMAB-RYVK
Overall Sentiment
Mixed
Comparison Threads
0
Avg Post Score
4 upvotes
Most discussed side effects in community
I’m a 49M Crohn’s veteran, pretty new to Reddit. I’ve been on Humira for the past 10 years with fantastic results. By far the longest remission period since I was diagnosed in 1986. Last summer I had a skin cancer spot on my ear, a basal cell. Had it removed via Moh’s surgery. Now I have another spo
REYKJAVIK, Iceland and PARSIPPANY, N.J., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Lt
SIMLANDI is the first interchangeable high-concentration, citrate-free biosimilar to Humira® PARSIPPANY, N.J. & REYKJAVÍK, Iceland--(BUSINESS WIRE)-- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Alvotech (NASDAQ: ALVO), today announced t
* In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination of interchangeability for SELARSDI * SELARSDI is the second biosimilar to launch in the U.S. under t
February 23, 2024 8:15 PM SIMLANDI is the first citrate-free, high-concentration biosimilar to be designated interchangeable to Humira in the U.S. SIMLANDI is the first biosimilar approval under the strategic partnership between Alvotech and Teva in the U.S. market SIMLANDI will qualify for intercha
Alvotech will manufacture its high-concentration interchangeable biosimilar to Humira® (adalimumab) for Quallent Pharmaceuticals The strategic agreement is in alignment with Alvotech’s U.S. commercialization agreement with Teva Pharmaceuticals The high-concentration interchangeable biosimilar to Hum
* Approval of SELARSDI 130 mg/26 mL in a single-dose vial for intravenous infusion expands label to include treatment of adults with Crohn’s disease and ulcerative colitis * The FDA previously approved SELARSDI 45 mg/0.5 mL and 90 mg/mL in a single-dose prefilled syringe for subcutaneous injection i
Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.
Both ADALIMUMAB-ADBM and ADALIMUMAB-RYVK belong to the TNF Inhibitor class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients. ADALIMUMAB-ADBM is administered via Oral, whereas ADALIMUMAB-RYVK uses Subcutaneous. Route of administration can affect onset of action and patient adherence.
Both medications are approved for inducing major clinical response, inhibiting the progression of structural damage, inhibiting the progression of structural damage, posterior. When two drugs treat the same condition, the choice between them often depends on the patient's medical history, other medications, tolerability, and prescriber preference.
ADALIMUMAB-ADBM carries 4 FDA warnings. ADALIMUMAB-RYVK carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..
This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.